Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles

The diagnostic criteria for schizophrenia (SCZ) and bipolar disorder (BD) are based on clinical assessments of symptoms. In this pilot study, we applied high-throughput antibody-based protein profiling to serum samples of healthy controls and individuals with SCZ and BD with the aim of identifying d...

Descripción completa

Detalles Bibliográficos
Autores principales: Oraki Kohshour, Mojtaba, Kannaiyan, Nirmal R., Falk, August Jernbom, Papiol, Sergi, Heilbronner, Urs, Budde, Monika, Kalman, Janos L., Schulte, Eva C., Rietschel, Marcella, Witt, Stephanie, Forstner, Andreas J., Heilmann-Heimbach, Stefanie, Nöthen, Markus M., Spitzer, Carsten, Malchow, Berend, Müller, Thorsten, Wiltfang, Jens, Falkai, Peter, Schmitt, Andrea, Rossner, Moritz J., Nilsson, Peter, Schulze, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646817/
https://www.ncbi.nlm.nih.gov/pubmed/36351892
http://dx.doi.org/10.1038/s41398-022-02228-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646817/
https://www.ncbi.nlm.nih.gov/pubmed/36351892
http://dx.doi.org/10.1038/s41398-022-02228-x

Ejemplares similares